RxDoctor Payments Data

Christina Carlton, APRN

Family · Gainesville, FLNPI 1912664822

Payments from drug & device makers

$2,118in general payments, 2019–2025

Across 122 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$488
  • Lilly USA, LLC$279
  • Medtronic$275
  • Astellas Pharma US Inc$227
  • Sumitomo Pharma America, Inc.$142
  • Pfizer$108
  • plus $599 from 13 others

What the payments were for

  • Food & beverage$2,118100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,118 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$38,621
Medicare patients
264
Services billed
793

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron45$41,850
MyrbetriqMirabegron41$32,590
MounjaroTirzepatide11$11,416
ProgesteroneProgesterone, Micronized316$9,945
Estradiol145$9,033
Liothyronine Sodium121$3,670
Methenamine Hippurate36$2,023
Levothyroxine Sodium133$846
Doxycycline Hyclate58$587
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav64$583
Minoxidil41$493
Solifenacin Succinate12$388
Metronidazole15$377
Albuterol Sulfate HfaAlbuterol Sulfate15$366
Tamsulosin Hcl27$347

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$142$41,85045 claims
Astellas Pharma US IncMyrbetriq$227$32,59041 claims
Lilly USA, LLCMounjaro$279$11,41611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.

Other family in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →